17:09 EDT Moleculin Biotech files $200M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech to Present Research at EHA2024 Hybrid Congress
- Moleculin Biotech Initiates Phase 2 Glioblastoma Treatment Study
- Moleculin Biotech begins Phase 2 study evaluating WP1066
- Moleculin Biotech Updates Investors with Corporate Presentation
- Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
Questions or Comments about the article? Write to editor@tipranks.com